Concepedia

Rengyun Liu

RL

Statistics

Publications

40

Citations

3.5K

H-Index

27

Active since

2008

Affiliations

Johns Hopkins University(Current)

Johns Hopkins Medicine

Soochow University

The First Affiliated Hospital, Sun Yat-sen University

Sun Yat-sen University

Rengyun Liu is an author at Johns Hopkins University specializing in medicine, cancer research, and radiation oncology.

ORCID

Top concepts

Publications per year

2008–2024

40

Publications

40

<i>BRAF</i> V600E and <i>TERT</i> Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence

Mingzhao Xing, Rengyun Liu, Xiaoli Liu et al. · Journal of Clinical Oncology · 2014 · 691 citations · Full text

<i>TERT</i>Promoter Mutations and Their Association with<i>BRAF</i>V600E Mutation and Aggressive Clinicopathological Characteristics of Thyroid Cancer

Xiaoli Liu, Shen Qu, Rengyun Liu et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 306 citations · Full text

JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells

Rengyun Liu, Yuanyuan Zeng, Zhe Lei et al. · International Journal of Oncology · 2014 · 299 citations · Full text

, , +24

Mortality Risk Stratification by Combining <i>BRAF </i>V600E and <i>TERT</i> Promoter Mutations in Papillary Thyroid Cancer

Rengyun Liu, Justin A. Bishop, Guangwu Zhu et al. · JAMA Oncology · 2016 · 275 citations

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants

Xiaoguang Shi, Rengyun Liu, Fulvio Basolo et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 201 citations · Full text

1–5 of 40